All premium reports for Pharmaceutical Industry Analysis and Statistics in Japan (since 2008)

 

1-30 of 60 Premium Reports from 11 Publishers

Blood Glucose Testing and Diabetes Management

Blood Glucose Testing and Diabetes Management

  • $ 3 400
  • April 2009
  • 366 pages

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked t ...

Industries : Diagnostics, Medical Equipment and Supply, Pathology | Countries : USA, Japan, France

Drug Retailers in Japan

Drug Retailers in Japan

  • $ 950
  • February 2009
  • 200 pages

The Plimsoll Portfolio Analysis - Drug Retailers is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance of the companies important to the success of your business. Using the most up to date information available, the analysis is ...

Industries : Pharmaceutical | Countries : Japan

Drug Wholesalers in Japan

Drug Wholesalers in Japan

  • $ 950
  • February 2009
  • 200 pages

The Plimsoll Portfolio Analysis - Drug Wholesalers is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance of the companies important to the success of your business. Using the most up to date information available, the analysis i ...

Industries : Pharmaceutical | Countries : Japan

Pharmaceutical in Japan

Pharmaceutical in Japan

  • $ 950
  • February 2009
  • 600 pages

The Plimsoll Portfolio Analysis - Pharmaceutical is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance of the companies important to the success of your business. Using the most up to date information available, the analysis is ...

Industries : Pharmaceutical | Countries : Japan

Pharmaceutical Manufacturers in Japan

Pharmaceutical Manufacturers in Japan

  • $ 950
  • February 2009
  • 250 pages

The Plimsoll Portfolio Analysis - Pharmaceutical Manufacturers is a comprehensive evaluation of the Japanese market. The revised and updated 2008 edition analyses the financial performance of the companies important to the success of your business. Using the most up to date information available, th ...

Industries : Pharmaceutical | Countries : Japan

Japanese Generic Market Forecast to 2013

Japanese Generic Market Forecast to 2013

  • $ 8 000
  • January 2009
  • 50 pages

According to ?Japanese Generic Market Forecast to 2013?, a new research report by RNCOS, Japan promises to be one of the most lucrative generic markets in the world. Between 2005 and 2008, the Japanese generics market grew at a CAGR of around 7.5% to register ¥ 333 Billion (US$ 3.5 Billion) in reve ...

Industries : Pharmaceutical | Countries : Japan

OTC Pharmaceuticals in the United States

OTC Pharmaceuticals in the United States

  • $ 250
  • September 2008
  • 34 pages

Datamonitor's OTC Pharmaceuticals in the United States industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive ...

Industries : Over-The-Counter Drug | Countries : Mexico, Brazil, Canada, USA, China, Japan, Taiwan, India, Singapore, Russia, Hungary, Poland, Czech Republic, Denmark, Norway, Sweden, Germany, Belgium, Spain, France, Italy, Netherlands, United Kingdom, Australia

OTC Pharmaceuticals in Europe

OTC Pharmaceuticals in Europe

  • $ 250
  • August 2008
  • 34 pages

Datamonitor's OTC Pharmaceuticals in Europe industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, ...

Industries : Over-The-Counter Drug | Countries : Mexico, Brazil, Canada, USA, China, Japan, Taiwan, India, Singapore, Russia, Hungary, Poland, Czech Republic, Denmark, Norway, Sweden, Germany, Belgium, Spain, France, Italy, Netherlands, United Kingdom, Australia

OTC Pharmaceuticals in China

OTC Pharmaceuticals in China

  • $ 250
  • August 2008
  • 29 pages

Datamonitor's OTC Pharmaceuticals in China industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, ...

Industries : Over-The-Counter Drug | Countries : China, Japan, Taiwan, India, Singapore, Australia

OTC Pharmaceuticals in Asia-Pacific

OTC Pharmaceuticals in Asia-Pacific

  • $ 250
  • August 2008
  • 30 pages

Datamonitor's OTC Pharmaceuticals in Asia-Pacific industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive land ...

Industries : Over-The-Counter Drug | Countries : Mexico, Brazil, Canada, USA, China, Japan, Taiwan, India, Singapore, Russia, Hungary, Poland, Czech Republic, Denmark, Norway, Sweden, Germany, Belgium, Spain, France, Italy, Netherlands, United Kingdom, Australia

Global OTC Pharmaceuticals

Global OTC Pharmaceuticals

  • $ 250
  • August 2008
  • 33 pages

Datamonitor's Global OTC Pharmaceuticals industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, le ...

Industries : Over-The-Counter Drug | Countries : Mexico, Brazil, Canada, USA, China, Japan, Taiwan, India, Singapore, Russia, Hungary, Poland, Czech Republic, Denmark, Norway, Sweden, Germany, Belgium, Spain, France, Italy, Netherlands, United Kingdom, Australia

Japanese Drug Sector: Industry Profile

Japanese Drug Sector: Industry Profile

  • $ 600
  • June 2008
  • 25 pages

This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...

Industries : Pharmaceutical | Countries : USA, Japan

Japanese Pharmaceutical Sector: Industry Profile

Japanese Pharmaceutical Sector: Industry Profile

  • $ 600
  • June 2008
  • 25 pages

This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...

Industries : Pharmaceutical | Countries : USA, Japan

Global market review of functional foods ? forecasts to 2013

Global market review of functional foods ? forecasts to 2013

  • $ 586
  • May 2008
  • 77 pages

By 2013, just-food estimates that the global functional food market is expected to reach a value of at least US$90.5bn. The report aims to quantify future profit opportunities in the functional food market to 2013, with just-food analysing the major drivers and trends in order to better understand t ...

Industries : Vitamin and Supplement, Diet Food | Countries : USA, China, Japan, Australia

Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses - Provides analysis of recent events in the osteoarthritis disease area and their impact on the market. Includes an event-based, indication-specific ten year forecast of both pipeline and mar

Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses - Provides analysis of recent events in the osteoarthritis disease area and their impact on the market. Includes an event-based, indication-specific ten year forecast of both pipeline and mar

  • $ 15 200
  • May 2008
  • 71 pages

IntroductionWith several recent non-approvable decisions in the osteoarthritis market since 2006, Datamonitor has updated its forecast to account for the effect on the market. We have revised the market outlook over the next 10 years using the latest IMS data. We expect the market to grow steadily, ...

Industries : Pharmaceutical | Countries : Mexico, Brazil, Canada, USA, Japan, Croatia, Germany, Spain, France, Italy, United Kingdom, Australia

Pipeline Insight: Acute Stroke: Commercial risk offsets high unmet need

Pipeline Insight: Acute Stroke: Commercial risk offsets high unmet need

  • $ 11 400
  • May 2008
  • 295 pages

IntroductionStroke is one of the top three causes of death and its incidence in the seven major markets is expected to increase in the next ten years because of an aging population. Long term disability caused by stroke is a major economic burden on healthcare systems, current treatment options are ...

Industries : Pharmaceutical | Countries : Japan

Cancer Therapeutics Markets

Cancer Therapeutics Markets

  • $ 3 400
  • May 2008
  • 160 pages

Cancer is the second leading cause of death by disease in the United States, exceeded only by heart disease. Traditionally cancer has been treated with surgery, chemotherapy, hormones and radiation therapy, alone or in combination. Emerging technologies include photodynamic therapy, gene therapy, bi ...

Industries : Pharmaceutical | Countries : USA, Japan, United Kingdom

Cardiac Marker Diagnostic Testing Markets

Cardiac Marker Diagnostic Testing Markets

  • $ 3 400
  • May 2008
  • 154 pages

The purpose of this report is to describe the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing. This study examines clinical measurement devices and their reagents and supplies as used in hospitals, clinics and doctor?s offices. This examination is ...

Industries : Diagnostics, Medical Equipment and Supply, Pathology | Countries : Canada, USA, China, Japan, Germany, Belgium, Spain, France, Italy, Switzerland

Pharmaceuticals in Singapore

Pharmaceuticals in Singapore

  • $ 250
  • April 2008
  • 35 pages

Datamonitor's Pharmaceuticals in Singapore industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, lead ...

Industries : Pharmaceutical | Countries : China, Japan, Taiwan, India, Singapore, Australia

OTC Pharmaceuticals in Singapore

OTC Pharmaceuticals in Singapore

  • $ 250
  • April 2008
  • 31 pages

Datamonitor's OTC Pharmaceuticals in Singapore industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landsca ...

Industries : Over-The-Counter Drug | Countries : China, Japan, Taiwan, India, Singapore, Australia

Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment and grow the market

Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment and grow the market

  • $ 15 200
  • March 2008
  • 233 pages

IntroductionThe opioid market is currently valued at $7.7 billion and is set to increase over the next 10 years at a CAGR of 2.4%. Despite this market being exclusively comprised of old genericized molecules, novel formulations and delivery methods have stimulated growth over the last 5 years. This ...

Industries : Pharmaceutical | Countries : USA, Japan, Croatia

Pipeline and Commercial Insight: Alzheimer's Disease - Scenario forecasts reveal vast market potential

Pipeline and Commercial Insight: Alzheimer's Disease - Scenario forecasts reveal vast market potential

  • $ 15 200
  • March 2008
  • 222 pages

IntroductionWith the AD market entering a pivotal phase, Datamonitor has conducted several scenario forecasts in order to explore the possible market outlook over the next 10 years. Several pioneering Phase III disease slowing therapies offer blockbuster potential. However, should these drugs fail P ...

Industries : Pharmaceutical | Countries : USA, Japan, Croatia

Sleep Disorders Market Analysis 2008-2018

Sleep Disorders Market Analysis 2008-2018

  • $ 2 501
  • March 2008
  • 250 pages

More than 80 sleep disorders have been identified. They affect over 200 million people worldwide. The report focuses on the market for following sleep disorders: Insomnia Restless legs syndrome (RLS) Narcolepsy and Obstructive Sleep Apnoea / Hypopnea Syndrome (OSAHS) The market penetration for insom ...

Industries : Pharmaceutical | Countries : USA, Japan, Germany, Spain, France, Italy, United Kingdom

Global Cardiovascular/Cardiology Devices Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Cardiac Rhythm Management, Interventional Cardiology, Cardiac Surgery, Prosthetic Devices, Peripheral Vascular Devices,

Global Cardiovascular/Cardiology Devices Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Cardiac Rhythm Management, Interventional Cardiology, Cardiac Surgery, Prosthetic Devices, Peripheral Vascular Devices,

  • $ 7 500
  • March 2008
  • 200 pages

Summary? This report is an essential source for key information and data relating to the Global cardiovascular devices market. The report provides overview of key trends, drivers and restraints, future outlook, pipeline products, news, financial deals and competitive landscape and key developments i ...

Industries : Pathology | Countries : USA, Japan, Germany, Spain, France, Italy, United Kingdom

Stakeholder Opinions: Systemic Lupus Erythematosus - Market set to enter era of biologic therapies

Stakeholder Opinions: Systemic Lupus Erythematosus - Market set to enter era of biologic therapies

  • $ 3 800
  • March 2008
  • 108 pages

IntroductionSLE is a chronic, life-long and potentially fatal autoimmune disease characterized by multiple system distress and unpredictable flares. Therapy is largely off-label and a huge demand exists for new SLE therapies because of the potential for serious side effects from drugs currently used ...

Industries : Pharmaceutical | Countries : Mexico, Canada, USA, China, Japan, India, Croatia, Germany, Spain, France, Italy, United Kingdom

The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma

The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma

  • $ 5 700
  • March 2008
  • 187 pages

IntroductionToday, pharma companies face growing competition from generics and me-too drugs, combined with increasingly tough P&R, a clamp down on healthcare spending, and the need to treat patients for longer due to the aging population. These factors threaten both current and future revenues promp ...

Industries : Pharmaceutical | Countries : USA, China, Japan, India, Spain, France, United Kingdom

Key Topics in Pharmaceutical Market Strategy 2008 (Drug Pricing, Rx to OTC switches, Retail Clinics, Prescribing Pharmacists, The Growing Out of Pocket Healthcare Market)

Key Topics in Pharmaceutical Market Strategy 2008 (Drug Pricing, Rx to OTC switches, Retail Clinics, Prescribing Pharmacists, The Growing Out of Pocket Healthcare Market)

  • $ 6 995
  • March 2008

Pharmaceutical marketers will face a challenging time in 2008 by all reports. Understanding the dynamics of the market can assist in better planning and strategy. This Kalorama Information Report Bundle combines 5 of the most important topics for those in the pharmaceutical industry in a strategic p ...

Industries : Pharmaceutical | Countries : USA, Japan, Germany, Spain, France, Ireland, Italy

Threshold Pharmaceuticals Inc: Premium Company Profile

Threshold Pharmaceuticals Inc: Premium Company Profile

  • $ 495
  • March 2008
  • 45 pages

IntroductionThreshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of drugs based on metabolic targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased cells. The company uses metabolic ta ...

Industries : Pharmaceutical | Countries : China, Hong Kong, Japan, Taiwan, India

 Parkinson?s Disease Market analysis and forecasts, 2008-2012, 2017 and 2022

Parkinson?s Disease Market analysis and forecasts, 2008-2012, 2017 and 2022

  • $ 2 501
  • March 2008
  • 150 pages

Parkinson's disease (PD) is the second most common neurological disorder, affecting approximately 4.1m people worldwide. As the prevalence rate of PD is set to rise significantly in the coming years, clinical interventions will play a major role in combating the wide spectrum of unmet needs associat ...

Industries : Pharmaceutical, Therapy | Countries : USA, Japan, Germany, Spain, France, Italy, United Kingdom

Impact of Pharmacogenomics on Public Healthcare Policy: Educating patients, payors and healthcare providers

Impact of Pharmacogenomics on Public Healthcare Policy: Educating patients, payors and healthcare providers

  • $ 3 835
  • March 2008
  • 171 pages

Impact of Pharmacogenomics on Public Healthcare PolicyImmense advances in genetic code decipherment over the last decade have recently led to personalized medicine, or ?the right drug for the right person?, becoming an achievable concept. Pharmacogenomics (PGx) embodies the principles of personalize ...

Industries : Pharmaceutical | Countries : USA, Japan

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.